Clinical Trial Update: A Phase III Clinical Trial for Efficacy and Safety Evaluation of JP-1366 Tablets on Reflux Esophagitis [Phase 3]

View source ↗

Summary

A Phase III clinical trial evaluating the efficacy and safety of JP-1366 tablets for reflux esophagitis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Reflux Esophagitis

Drugs mentioned

• JP-1366 Tablets (JP-1366)

Snippet

Sponsor: Livzon Pharmaceutical Group Inc. | Conditions: Reflux Esophagitis (RE) | Phase 3 | Status: RECRUITING